Examining the Future of In Vitro Diagnostics

New report analyzes the market globally, based on market and supply chain trends, technological innovations and future strategies.

In Vitro Diagnostics, reports the U.S. FDA, “are tests that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.”

In its “Global In Vitro Diagnostics (IVD) Market Analysis & Trends - Industry Forecast to 2025,” Research and Markets predicts the global IVD market to grow at a CAGR (Compound Annual Growth Rate) of around 6.3% over the next decade to reach approximately $101.8 billion by 2025.

This industry report analyzes the global IVD markets across all the given segments on global and regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 through 2025.

The study focuses on market trends, leading companies—such as Abbott, Roche Diagnostics and Bayer Ag—supply chain trends, technological innovations, key developments, and future strategies.

Market assessments are made across North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the World.

The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

IVD markets are examined by end users, by products, by application, by technology, and by geography.

More in Home